Key facts
- Hero (Healthcare Technology Systems)’s last known valuation is $200.0M (May 2025).
- It has raised $94.0M; the latest was Later Stage VC ($61.0M) in May 2025.
- Notable investors include BoxGroup, Elad Gil, Company Ventures, Naval Ravikant, Wormhole Capital — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Hero (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Hero (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hero (Healthcare Technology Systems)
Developer of a remote medication management platform designed to facilitate patient engagement. The company's platform uses digital technologies to collect and monitor non-physiologic health data such as medication use and adherence from patients with chronic diseases, enabling patients with medication monitoring that provides enhanced visibility into adherence, which is critical for improving patient outcomes.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2015
- Employees
- 328
- Website
- herohealth.com/
- Ownership
- Privately Held (backing)
Hero (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hero (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hero (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.